CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kogevinas, M.
Right arrow Articles by de Sanjose, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kogevinas, M.
Right arrow Articles by de Sanjose, S.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 1814-1818, November 2004
© 2004 American Association for Cancer Research


Short Communication

Occupational Exposure to Immunologically Active Agents and Risk for Lymphoma

Manolis Kogevinas1, Jan-Paul Zock1, Tomas Alvaro4, Mercedes Garcia-Villanueva5, Eva Domingo-Domenech2, Susan Kennedy6, Otoniel Martínez-Maza7 and Silvia de Sanjose3

1 Respiratory and Environmental Health Research Unit, Municipal Institute of Medical Research; 2 Hematologia Oncologica and 3 Epidemiology and Cancer Registry, Catalan Institute of Oncology, Barcelona, Spain; 4 Department of Pathology, Hospital Verge de la Cinta, Tortosa, Spain; 5 Department of Pathology, Hospital Ramon y Cajal, Universidad de Alcalá, Madrid, Spain; 6 University of British Columbia, Vancouver, British Columbia, Canada; and 7 Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California

Requests for reprints: Silvia de Sanjose, Servei d'Epidemiologia & Registre del Cancer, Institut Catala d'Oncologia, Gran Via Km 2.7, 08907 L'Hospitalet, Barcelona, Spain. Phone: 34-93-260-7812; Fax: 34-93-260-7787. E-mail: s.sanjose{at}ico.scs.es

Objectives: We evaluated whether occupational exposure to high molecular weight agents that are associated with asthma and that act predominantly through an immunoglobulin E (IgE)–dependent hypersensitivity mechanism is also associated with risk for specific lymphoma types.

Methods: The Spanish lymphoma case-control study includes 519 newly diagnosed cases of lymphoid neoplasms and 554 hospital controls ages 20 to 80 years. Lymphomas were histologically or cytologically confirmed and classified according to the WHO classification. Lifetime occupational exposure to seven high molecular weight agents such as latex was evaluated through an asthma-specific job-exposure matrix and validated by an industrial hygienist. Odds ratios (OR) and 95% confidence intervals (95% CI) were adjusted for age, sex, hospital, and occupational exposures.

Results: Subjects exposed to high molecular weight agents had an increased risk for Hodgkin's lymphoma (OR, 2.27; 95% CI, 0.93-5.50), particularly nodular sclerosis (OR, 3.22; 95% CI, 1.14-9.09). ORs did not increase with duration of exposure to these agents. Exposure to high molecular weight agents was not associated with risk of other B-cell lymphomas; for most specific subcategories of B-cell lymphoma, ORs were below unity. A slightly increased OR (95% CI) was seen for mycosis fungoides [1.60 (0.53-4.84)], although overall there was no increased risk for T-cell lymphomas.

Conclusions: Exposure to immunologically active agents among clinically immunocompetent subjects was associated with risk for Hodgkin's lymphoma.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Ellison-Loschmann, Y. Benavente, J. Douwes, E. Buendia, R. Font, T. Alvaro, M. Kogevinas, and S. de Sanjose
Immunoglobulin E Levels and Risk of Lymphoma in a Case-Control Study in Spain
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1492 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
E van Balen, R Font, N Cavalle, L Font, M Garcia-Villanueva, Y Benavente, P Brennan, and S de Sanjose
Exposure to non-arsenic pesticides is associated with lymphoma among farmers in Spain
Occup. Environ. Med., October 1, 2006; 63(10): 663 - 668.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.